JPM: the bull case, the bear case, and the verdict
The bull case
Let me be direct: the bear case on JPM is built on selective data interpretation and fails to account for the company's structural advantages, earnings quality, and the favorable macro backdrop we're entering. The concerns raised are surface-level—and when we dig deeper, they actually validate the bull thesis.
Let me walk through why JPM at $333-350 represents a compelling value opportunity with significant upside potential.
Part 1: Earnings growth is real, not an illusion
The "Special Items Manipulation" Argument Doesn't Hold Water
The Bear Claim: "Q2's $21.2B net income is inflated by $4.4B in special items. Normalize it and earnings are pedestrian."
Yes, Q2 benefited from $4.4B in securities gains. But let's be intellectually honest about what this means:
- This isn't "one-time" in the way bears suggest. JPM's investment portfolio generated $1,586.7B in trading securities. These aren't passive holdings—JPM actively manages this for gains. Securities gains are recurring and part of the operating model, not surprise windfalls. In Q1 2026, the company had to take charges. In Q2, it harvested gains. This is cycle management within normal operations.
- Even normalized, earnings are stellar. If we strip out the $4.4B gain and use normalized Q2 net income of $17.8B, that's:
- $17.8B ÷ 2,694.2M shares = $6.60 EPS (normalized)
- Compare to Q2 2025 normalized: roughly $4.70 EPS
- That's still 40% YoY growth on normalized earnings
- That still beats expectations
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The bear case
Opening salvo
I appreciate the bull's passion, but let me be equally direct: the bull case is built on cherry-picked data, dangerous assumptions about macro stability, and a willful blindness to warning signs that are flashing red. JPM at $333-350 isn't a value opportunity—it's a value trap masquerading as quality. And the bull's confidence of 72% should be a warning to any rational investor.
Let me methodically dismantle this thesis.
Part 1: The earnings quality issue is worse than the bull admits
"Normalized Earnings Still Grew 40%" — This Ignores the Deteriorating Trend
The bull claims: "Even stripping special items, normalized EPS grew 40% YoY. That's still exceptional."
Here's what they're hiding in that number
Let me look at the actual normalized earnings trajectory:
| Quarter | Reported EPS | Special Items | Normalized EPS | YoY Growth |
|---|---|---|---|---|
| Q2 2025 | $5.24 | ~$0.54 | ~$4.70 | — |
| Q3 2025 | $5.07 | -$0.62 | ~$5.69 | +21% |
| Q4 2025 | $4.63 | -$0.70 | ~$5.33 | -6% |
| Q1 2026 | $5.94 | -$0.94 | ~$6.88 | +21% |
| Q2 2026 | $7.70 | +$1.63 | ~$6.07 | +29% |
So the real normalized trend is: 21% → -6% → 21% → 29%
This is erratic and volatile, not the smooth, predictable growth the bull is selling. The Q2 2026 "40% growth" is primarily driven by:
- A rebound from Q1's depressed earnings (-$0.94B in charges)
- A $4.4B securities gain that's explicitly noted as one-time
Strip out the rebound effect, and normalized organic growth is closer to 15-20%, not 40%.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The research manager's call
Recommendation: Overweight
Rationale: This was a high-quality debate with both sides making substantive arguments. Let me walk through where the weight of evidence actually falls.
Where the Bear landed punches
The bear's strongest arguments were around NII deceleration (QoQ growth collapsing from +4.2% to +0.4%), the asymmetric rate dependency of the entire bull thesis, and the late-cycle credit risk embedded in receivables growing 4.3x faster than total assets. The point about the October 28 FOMC being a binary catalyst is real, and the "debt tsunami" macro backdrop is genuinely concerning. The bear is also right that normalized earnings growth is closer to 15–20% than the 40% headline figure, once you strip out the rebound effect from Q1's depressed base. The 244% increase in net debt, while partly explained by cash redeployment, does represent a meaningful shift in the balance sheet's risk posture.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
Stress-test your own thesis on JPM (or any US stock)
Enter a ticker, your optional thesis, and your email. Nine AI analysts will argue the bull and bear case, test your reasoning, and email your 4-page PDF report.
Unlock the full trade plan & Trader desk
Stop loss and take profit levels, position sizing, the risk team's debate and the full transcript for JPM are in Pro ($39/mo or $379/yr, 5/day). Or upgrade to Trader ($99/mo or $949/yr, 10/day) for live position tracking vs the S&P 500, price/stop email alerts, weekly Monday AI thesis re-checks, and an Alpaca paper-trading order ticket.
Get Pro — $39/mo →Get Trader — $99/mo →5-Report Pack — $19 one-time →Founding Lifetime Pass — $499 (20 seats) →Other recent analyses
This page was generated automatically by HedgePick's AI agents from public market data. It is general information, not personalized investment advice, and not a recommendation to buy or sell any security. AI output can be wrong or out of date. HedgePick is not a registered investment adviser or broker-dealer. Do your own research and consider your own situation before trading.